HSP70 Inhibition: Efforts are underway to develop small-molecule inhibitors that target HSP70's chaperone function, potentially sensitising GBM cells to apoptosis or making them more susceptible to other therapeutic interventions. The gene discussed is HSPA1A; the disease is glioblastoma.